Eutropics Pharmaceuticals
Pre-clinicalEutropics’ PRIMABS-Dx platform translates mitochondrial priming biology into scalable, multiplexed, companion diagnostics that de-risk oncology pipelines to guide precision patient treatment.
Market Cap
Private
Pipeline
—
Patents
—
Publications
—
Private Company
Total funding raised: $39.5M
About
Eutropics’ PRIMABS-Dx platform translates mitochondrial priming biology into scalable, multiplexed, companion diagnostics that de-risk oncology pipelines to guide precision patient treatment.
Diagnostics
Funding History
3Total raised:$39.5M
Series B$25MJul 15, 2016
Series A$12MMar 15, 2014
Seed$2.5MJun 15, 2012